Close

Industry Reports

Merck total revenues increase 3.2% to € 2.6 billion

The Merck Group's first-quarter 2012 total revenues rose 3.2% to € 2,645 million compared to € 2,564 million in the first quarter of...

Infinity Reports First Quarter 2012 Financial Results

Infinity Pharmaceuticals, Inc.today reported its financial results for the first quarter of 2012. The company maintained its strong financial condition while continuing to...

Pfizer reports first-quarter 2012 results

Pfizer Inc. today reported financial results for first-quarter 2012. First-quarter 2012 revenues were $15.4 billion, a decrease of 7% compared with $16.5 billion...

Revenue of first quarter 2012

ADOCIA, a biotechnology company specialized in the development of best-in-class medicines with already-approved therapeutic proteins, announces today revenues of EUR 1.2 million for the...

Pfizer reports fourth-quarter and full-year 2011 results

Pfizer Inc. reported financial results for fourth-quarter and full-year 2011. Fourth-quarter 2011 revenues were $16.7 billion, a decrease of 4% compared with $17.4 billion in...

NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the fourth...

Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the fourth quarter and year ended December 31, 2011. The Company will host a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read